03/26/2024
3:40 PM | Kyverna Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:13 PM | Kyverna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:56 PM | Kyverna Therapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:03 PM | Cohen Fred E (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:04 PM | Kyverna Therapeutics (Issuer)
Vida Ventures GP III, L.L.C. (Reporting)
Vida Ventures III, L.P. (Reporting)
Vida Ventures III-A, L.P. (Reporting)
Vida Ventures, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
4:35 PM | Harper Sean E (Reporting)
Kyverna Therapeutics (Issuer)
Westlake BioPartners Fund I, L.P. (Reporting)
Westlake BioPartners GP I, LLC (Reporting)
Westlake BioPartners Opportunity Fund I, L.P. (Reporting)
Westlake BioPartners Opportunity GP I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
4:20 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by)
Kyverna Therapeutics (Subject)
| Form SC 13G | |
|
02/14/2024
4:26 PM | Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
Bain Capital Life Sciences Opportunities III GP, LLC (Reporting)
Bain Capital Life Sciences Opportunities III, LP (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:48 PM | GILEAD SCIENCES, INC. (Reporting)
Kyverna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:51 PM | Kyverna Therapeutics (Issuer)
Northpond Ventures III GP, LLC (Reporting)
Northpond Ventures III, LP (Reporting)
Rubin Michael P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:44 PM | Kyverna Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/08/2024
7:15 AM | Kyverna Therapeutics (Filer)
| Form CERT | |
02/07/2024
11:15 PM | Kyverna Therapeutics (Filer)
| Form EFFECT | |
02/08/2024
5:04 AM | Kyverna Therapeutics (Issuer)
Liapis Stephen Constantine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
5:10 AM | Kyverna Therapeutics (Issuer)
Liapis Stephen Constantine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:55 PM | Kyverna Therapeutics (Issuer)
Maag Peter (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:55 PM | Kyverna Therapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:56 PM | Jones Ryan Alexander (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:56 PM | Kyverna Therapeutics (Issuer)
Vida Ventures, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:57 PM | Kotzin Brian L. (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:57 PM | Chung James Bum (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:57 PM | Kyverna Therapeutics (Issuer)
Walker Karen Marie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:58 PM | Cohen Fred E (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:58 PM | CLARK IAN T (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:58 PM | Borie Dominique Christian (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:58 PM | Kyverna Therapeutics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:51 PM | Harper Sean E (Reporting)
Kyverna Therapeutics (Issuer)
Westlake BioPartners Fund I, L.P. (Reporting)
Westlake BioPartners GP I, LLC (Reporting)
Westlake BioPartners Opportunity Fund I, L.P. (Reporting)
Westlake BioPartners Opportunity GP I, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
8:23 PM | Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
Bain Capital Life Sciences Opportunities III GP, LLC (Reporting)
Bain Capital Life Sciences Opportunities III, LP (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
7:30 PM | Kyverna Therapeutics (Issuer)
Northpond Ventures III GP, LLC (Reporting)
Northpond Ventures III, LP (Reporting)
Rubin Michael P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2024
4:35 PM | GILEAD SCIENCES, INC. (Reporting)
Kyverna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2024
5:10 AM | Kyverna Therapeutics (Filer)
| Form S-1/A | |
02/05/2024
3:01 PM | Kyverna Therapeutics (Filer)
| Form 8-A12B | |
01/31/2024
8:47 PM | Kyverna Therapeutics (Filer)
| Form S-1/A | |
01/16/2024
3:46 PM | Kyverna Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/06/2023
6:53 PM | Kyverna Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
